You can find the annual or quarterly income statement of CERo Therapeutics Holdings Inc here for insights into the performance and operational efficiency of CERo Therapeutics Holdings Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

Operating expenses

-0.90%4.36M

-8.24%4.72M

8.75%4.95M

86.90%2.10M

186.68%4.40M

113.29%5.15M

86.69%4.55M

--1.12M

--1.54M

--2.41M

--2.44M

R&D expenses

34.50%2.39M

1.46%2.75M

74.31%2.91M

-9.34%922.98K

38.88%1.77M

127.51%2.71M

-7.32%1.67M

--1.02M

--1.28M

--1.19M

--1.80M

Depreciation, depletion, and amortization

-39.09%69.35K

-33.25%76.29K

-32.87%76.29K

-15.87%96.38K

-1.33%113.86K

-0.94%114.30K

-1.51%113.64K

--114.56K

--115.39K

Operating profit

0.90%-4.36M

8.24%-4.72M

-8.75%-4.95M

-86.90%-2.10M

-186.68%-4.40M

-113.29%-5.15M

-86.69%-4.55M

---1.12M

---1.54M

---2.41M

---2.44M

Net non-operating interest income (expenses)

Non-operating interest income

34.36%5.94K

--13.78K

--850.00

-81.72%48.84K

2714.01%4.42K

----

--267.22K

--157.00

--59.42K

--16.00

Special income (expenses)

194.12%500.00K

----

102.43%10.00K

-8.64%170.00K

1007.62%2.90M

--2.26M

---411.23K

--186.07K

--261.82K

--0.00

Other non-operating income (expenses)

-339867.35%-499.75K

-285.58%-707.30K

---156.25K

--2.71M

---147.00

---183.44K

----

--0.00

----

Income before tax

-14.86%-4.86M

-121.24%-5.42M

-122.03%-5.11M

153.11%671.89K

-213.33%-4.23M

-17.02%-2.45M

5.69%-2.30M

---1.27M

---1.35M

---2.09M

---2.44M

Income after tax

-14.86%-4.86M

-121.24%-5.42M

-122.03%-5.11M

153.11%671.89K

-213.33%-4.23M

-17.02%-2.45M

5.69%-2.30M

---1.27M

---1.35M

---2.09M

---2.44M

Net income from continuous operations

-14.86%-4.86M

-121.24%-5.42M

-122.03%-5.11M

153.11%671.89K

-213.33%-4.23M

-17.02%-2.45M

5.69%-2.30M

---1.27M

---1.35M

---2.09M

---2.44M

Net income attributable to controlling interests

-172.15%-11.51M

-1129.97%-30.12M

-137.17%-5.45M

-67.01%-2.11M

-213.33%-4.23M

-17.02%-2.45M

5.69%-2.30M

---1.27M

---1.35M

---2.09M

---2.44M

Preferred share dividend

--6.65M

--24.70M

--348.23K

--2.78M

----

Net income attributable to common shareholders

-172.15%-11.51M

-1129.97%-30.12M

-137.17%-5.45M

-67.01%-2.11M

-213.33%-4.23M

-17.02%-2.45M

5.69%-2.30M

---1.27M

---1.35M

---2.09M

---2.44M

Basic earnings per share

-217.40%-9.10

-473.01%-61.71

-103.52%-31.82

57.03%-3.65

68.34%-2.87

23.28%-10.77

4.40%-15.64

---8.49

---9.05

---14.04

---16.36

Diluted earnings per share

-217.40%-9.10

-473.01%-61.71

-103.52%-31.82

57.03%-3.65

68.34%-2.87

23.28%-10.77

4.40%-15.64

---8.49

---9.05

---14.04

---16.36

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

